Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Congress 2022

How to select patients for immunotherapy-based therapy in the first-line treatment for recurrent/metastatic head and neck squamous cell cancer

Presentation by Expert

Date

12 Sep 2022

Session

How to select patients for immunotherapy-based therapy in the first-line treatment for recurrent/metastatic head and neck squamous cell cancer

Topics

Tumour Site

Head and Neck Cancers

Presenters

Sjoukje Oosting

Authors

S. Oosting

Author affiliations

  • Groningen/NL

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

Discussion led by Chair 

Presenter: Amanda Psyrri

Session: How to select patients for immunotherapy-based therapy in the first-line treatment for recurrent/metastatic head and neck squamous cell cancer

Resources:

Slides

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.